James L. Zazzali

Roche (United States) — United States

Medicine · Health Sciences

23h-index2.3kcitations73works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Urticaria and Related Conditions(26), Asthma and respiratory diseases(17), Autoimmune Bullous Skin Diseases(13), Dermatology and Skin Diseases(12), Mast cells and histamine(7)

Publications73 total

The Development and Validation of the Comprehensive Assessment Tool for Challenges in Hemophilia (CATCH) 2.0
2024Open Access
Performance of the Comprehensive Assessment Tool for Challenges in Hemophilia (CATCH) 2.0
Blood·2022· 1 cited
Treatment patterns in US patients hospitalized with COVID‐19 and pulmonary involvement
Journal of Medical Virology·2021· 15 citedOpen Access
Treatment Patterns in US Patients Hospitalized With COVID-19 and Pulmonary Involvement
2020· 2 citedOpen Access
Baseline Demographics and Clinical Characteristics Among 3471 US Patients Hospitalized with COVID-19 and Pulmonary Involvement: A Retrospective Study
Advances in Therapy·2020· 18 citedOpen Access
The Added Burden of Allergen Sensitization Among Children with Severe or Poorly Controlled Asthma
The Journal of Allergy and Clinical Immunology In Practice·2020· 10 citedOpen Access
Baseline Demographics and Clinical Characteristics Among 3471 US Patients Hospitalized With COVID-19 and Pulmonary Involvement
2020Open Access
Validity and responsiveness of the Urticaria Activity and Impact Measure
Annals of Allergy Asthma & Immunology·2018· 9 citedOpen Access
Validity and Responsiveness of Urticaria Activity and Impact Measure (U-AIM), a New Patient-Reported Tool to Assess Disease Activity and Impact in Patients with Chronic Spontaneous/Idiopathic Urticaria (CSU/CIU)
Journal of Allergy and Clinical Immunology·2018Open Access
P161 Urticaria activity and impact measure (U-aim) evaluates CSU/CIU activity, impact, and control in clinical practice
Annals of Allergy Asthma & Immunology·2017
Omalizumab substantially improves dermatology‐related quality of life in patients with chronic spontaneous urticaria
Journal of the European Academy of Dermatology and Venereology·2017· 49 citedOpen Access
Importance of angioedema-free days in patients with chronic idiopathic or spontaneous urticaria
Annals of Allergy Asthma & Immunology·2017· 1 cited
Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studies
Annals of Allergy Asthma & Immunology·2016· 28 cited
Clinical and economic burden of idiopathic pulmonary fibrosis: a retrospective cohort study
BMC Pulmonary Medicine·2016· 96 citedOpen Access
Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria
Journal of Allergy and Clinical Immunology·2015· 193 citedOpen Access
In-Hospital Length of Stay and Mortality for Patients With Idiopathic Pulmonary Fibrosis (IPF) in the US
CHEST Journal·2015· 1 cited
The minimal important difference for measures of urticaria disease activity: Updated findings
Allergy and Asthma Proceedings·2015· 30 cited
Changes in asthma control, work productivity, and impairment with omalizumab: 5-year EXCELS study results
Allergy and Asthma Proceedings·2015· 36 cited
Risk of corticosteroid-related adverse events in asthma patients with high oral corticosteroid use
Allergy and Asthma Proceedings·2015· 76 cited
Omalizumab adherence in an observational study of patients with moderate to severe allergic asthma
Annals of Allergy Asthma & Immunology·2015· 24 cited
page 1 of 4Next →

Frequent Co-authors

Karin Rosén(8), Karina Raimundo(8), Eunice Chang(7), Michael S. Broder(7), Allen P. Kaplan(6), Marcus Maurer(6), Benjamin Trzaskoma(6), Evgeniya Antonova(5), Susan D. Mathias(5), Ross D. Crosby(4), Paul G. Solari(4), Michael Schätz(4), Theodore A. Omachi(3), Timothy F. Cloughesy(3), Jeffrey A. Alexander(3), Kimberly Jinnett(3), Jennie H. Best(3), Shalini Mohan(3), Amanda M. Kong(3), Otis W. Brawley(3)